DAWNRAYS PHARMA

02348
0.9101.68% ( +0.015 )
Delay Closed: Nov 17, 16:08:15

Valuation

Current ValuationThe current P/E ratio is 5.10, within the reasonable range, cheaper than 43.48% of the time in the past 3 years, and the industry ranks 2/53, the industry Median 6.96.

5.1xP/E
Stock priceHK$0.91Earnings per shareHK$0.18

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.96x
010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.96x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
02196HKFOSUN PHARMA
9.48x10.29%HK$38.81B
03320HKCHINARES PHARMA
5.88x7.23%HK$28.11B
01681HKCONSUN PHARMA
9.74x20.92%HK$13.17B
02877HKSHINEWAY PHARM
6.96x13.28%HK$6.45B
02186HKLUYE PHARMA
7.65x47.27%HK$6.13B
02633HKJACOBSON PHARMA
5.97x1.99%HK$1.80B
08049HKJILIN CHANGLONG
6.34x--HK$1.60B
02348HKDAWNRAYS PHARMA
5.10x--HK$1.37B
02161HKJBM HEALTHCARE
6.15x6.78%HK$1.24B
00239HKPAK FAH YEOW
7.42x--HK$733.91M
00950HKLEE'S PHARM
4.99x--HK$597.67M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.